Concert Pharmaceuticals' GAAP loss for three months 2021 was $22.669 million, up 10.7% from $20.477 million in the previous year. Revenues fell 28.6% to $5,000 from $7,000 a year earlier.
Concert Pharmaceuticals' GAAP loss for three months 2021 was $22.669 million, up 10.7% from $20.477 million in the previous year. Revenues fell 28.6% to $5,000 from $7,000 a year earlier. 
ir.concertpharma.com
English (US) 